JENNA COMSTOCK: Open Payments
NPI 1265159305 · SOUTH SIOUX CITY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,207 in 75 payments from 17 companies in 2025. Trend: 2023 $1,036 · 2024 $1,077 · 2025 $1,207
Food & beverage: $1,207
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $270 |
| AstraZeneca Pharmaceuticals LP | 12 | $216 |
| PFIZER INC. | 14 | $202 |
| Novo Nordisk Inc | 6 | $114 |
| Astellas Pharma US Inc | 5 | $77 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 3 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Radius Health, Inc. | 2 | $28 |
Products named: VRAYLAR, NURTEC ODT, Ozempic, ELIQUIS, Veozah, QULIPTA, Kerendia, CREON.
Industry payments across NE — which companies pay providers there.
